From randomized trial to practice: Single institution experience using the GOG 172 i.p. chemotherapy regimen for ovarian cancer

G. D. Aletti, D. Nordquist, L. Hartmann, M. Gallenberg, H. J. Long, W. A. Cliby

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Fingerprint

Dive into the research topics of 'From randomized trial to practice: Single institution experience using the GOG 172 i.p. chemotherapy regimen for ovarian cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences